Medroxyprogesterone acetate linked to immune suppression

Medroxyprogesterone acetate linked to immune suppression
Use of the injectable contraceptive depot medroxyprogesterone acetate, common in areas such as sub-Saharan Africa with high HIV-1 prevalence, is associated with suppression of the immune response, according to a study published online Jan. 25 in Endocrinology.

(HealthDay)—Use of the injectable contraceptive depot medroxyprogesterone acetate (MPA), common in areas such as sub-Saharan Africa with high HIV-1 prevalence, is associated with suppression of the immune response, according to a study published online Jan. 25 in Endocrinology.

Noting that observational studies indicate a correlation between hormonal contraceptives and acquisition and transmission of HIV-1, Richard P.H. Huijbregts, from the University of Alabama at Birmingham, and colleagues examined the effect of MPA and other hormones on innate and adaptive immune mechanisms.

The researchers found that, in and activated T cells, MPA inhibited many cytokines and chemokines, including interferon (IFN)-γ and (TNF)-α. produced less IFN-γ and TNF-α in response to ligands to several Toll-like receptors after MPA treatment. Use of depot MPA was associated with lower levels of IFN-γ in plasma and genital secretions. Lastly, the investigators found that MPA treatment blocked the down-regulation of the HIV-1 coreceptors CXCR4 and CCR5 after T cell activation and increased replication of HIV-1 in activated .

"The presented results suggest that MPA suppresses both innate and adaptive arms of the immune system resulting in a reduction of host resistance to invading pathogens," Huijbregts and colleagues conclude.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Scientists disarm HIV in step towards vaccine

date Sep 19, 2011

Researchers have found a way to prevent HIV from damaging the immune system, in a new lab-based study published in the journal Blood. The research, led by scientists at Imperial College London and Johns Hopkins University, ...

New HIV-inhibiting protein identified

date May 29, 2012

Scientists have identified a new HIV-suppressing protein in the blood of people infected with the virus. In laboratory studies, the protein, called CXCL4 or PF-4, binds to HIV such that it cannot attach to or enter a human ...

Oregon study raises questions on synthetic progestins

date Mar 10, 2008

The widely used synthetic progestin medroxyprogesterone acetate (MPA) decreased endothelial function in premenopausal women in a study done at the University of Oregon. The finding, researchers said, raises concerns about ...

Recommended for you

How to avoid July Fourth allergy flare-ups

date Jul 03, 2015

Fireworks, picnics and parades are favorite Fourth of July traditions for many people, but for those with allergies or asthma these activities could be uncomfortable or even dangerous.

Researchers discover the cause of coeliac disease

date Jun 30, 2015

Professor Ludvig M. Sollid and his colleagues at the University of Oslo have found the cause of coeliac disease. To do so required really going into depth, right down to molecular level. 

Mechanism of T cell self / non-self “education”

date Jun 30, 2015

Researchers at the University of Tokyo have demonstrated that a protease only found in the thymus produces special peptides that promote positive selection of T cells that can detect non-self antigens, a ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.